PCSK9 and diabetes mellitus: Therefore, it is recommended that patients at high risk of diabetes choose statins as the basic lipid-lowering therapy, and if LDL-C is not achieved, a combination of cholesterol absorption inhibitor or PCSK9 inhibitor is required (Cannon et al., 2015; Sabatine et al., 2017).